Location of Repository

Ambulatory oxygen: why do COPD patients not use their portable systems as prescribed? A qualitative study

By Elizabeth Arnold, Anne Bruton, Maggie Donovan-Hall, Angela Fenwick, Bridget Dibb and Elizabeth Walker


Background: patients with COPD on long term oxygen therapy frequently do not adhere to their prescription, and they frequently do not use their ambulatory oxygen systems as intended. Reasons for this lack of adherence are not known. The aim of this study was to obtain in-depth information about perceptions and use of prescribed ambulatory oxygen systems from patients with COPD to inform ambulatory oxygen design, prescription and management.<br/><br/>Methods: a qualitative design was used, involving semi-structured face-to-face interviews informed by a grounded theory approach. Twenty-seven UK community-dwelling COPD patients using NHS prescribed ambulatory systems were recruited. Ambulatory oxygen systems comprised cylinders weighing 3.4 kg, a shoulder bag and nasal cannulae.<br/><br/>Results: participants reported that they: received no instruction on how to use ambulatory oxygen; were uncertain of the benefits; were afraid the system would run out while they were using it (due to lack of confidence in the cylinder gauge); were embarrassed at being seen with the system in public; and were unable to carry the system because of the cylinder weight. The essential role of carers was also highlighted, as participants with no immediate carers did not use ambulatory oxygen outside the house.<br/><br/>Conclusions: these participants highlighted previously unreported problems that prevented them from using ambulatory oxygen as prescribed. Our novel findings point to: concerns with the lack of specific information provision; the perceived unreliability of the oxygen system; important carer issues surrounding managing and using ambulatory oxygen equipment. All of these issues, as well as previously reported problems with system weight and patient embarrassment, should be addressed to improve adherence to ambulatory oxygen prescription and enhance the physical and social benefits of maintaining mobility in this patient group. Increased user involvement in both system development and service provision planning, could have avoided many of the difficulties highlighted by this stud

Topics: BF, RA, RM
Year: 2011
OAI identifier: oai:eprints.soton.ac.uk:176539
Provided by: e-Prints Soton

Suggested articles



  1. (2007). A connection between medication adherence, patient sense of uniqueness, and the personalization of information. Med Hypotheses doi
  2. (2008). Calverley PM: Drugs (including oxygen) in severe COPD. doi
  3. (2007). Charmaz K: Grounded Theory in historical perspective: an epistemological account. doi
  4. (1982). Chronic illness as biographical disruption. Sociol Health Illn doi
  5. (2010). Consultation on a strategy for services for chronic obstructive pulmonary disease (COPD) in doi
  6. (2006). Cost-effectiveness and efficacy in long-term oxygen therapy. Nurs Times doi
  7. (2007). et al: Effects of rehabilitative exercise on peripheral muscle TNFalpha, IL-6, IGF-I and MyoD expression in patients with COPD. Thorax doi
  8. (2008). et al: Medication adherence issues in patients treated for COPD.
  9. (2002). Explaining adherence to supplemental oxygen therapy: the patient’s perspective. doi
  10. (2005). F: Randomised trial of ambulatory oxygen in oxygen-dependent COPD. Eur Respir J doi
  11. (2009). FS: We need minimally disruptive medicine. BMJ doi
  12. (2008). HC: Issues and challenges of involving users in medical device development. Health Expect doi
  13. (2005). K: Factors associated with medication nonadherence in patients with COPD. Chest doi
  14. (2004). Long-term oxygen therapy improves health-related quality of life. Respir Med doi
  15. (2009). Medication non-adherence–exploring the conceptual mire. doi
  16. (2010). Multidisciplinary Assessment of Technology Centre for Healthcare (MATCH):
  17. (2007). Oxygen therapy in COPD: what do we know? Am J Respir Crit Care Med doi
  18. (2003). Piran N: Rigour and grounded theory research. doi
  19. (2000). PL: Ambulatory oxygen therapy, exercise, and survival with advanced chronic obstructive pulmonary disease (the Nocturnal Oxygen Therapy Trial revisited). Respir Care
  20. (2000). Rooijmans HG: Physical and psychological correlates of functioning in patients with chronic obstructive pulmonary disease. doi
  21. (2007). RS: Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia. Am J Respir Crit Care Med doi
  22. (2008). Safety, simplicity and convenience of a modified prefilled insulin pen. Expert Opin Pharmacother doi
  23. (2008). Sharafkhaneh A: Oxygen therapy in chronic obstructive pulmonary disease. Proc Am Thorac Soc doi
  24. (2008). SJ: Patient adherence in COPD. Thorax doi
  25. (2001). Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis
  26. (2007). Support for self care for patients with chronic disease. BMJ doi
  27. (1999). Viskum K: Compliance with LTOT and consumption of mobile oxygen. Respir Med doi
  28. (2006). WC: Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report. Am J Respir Crit Care Med doi
  29. (2007). What really matters to patients living with chronic obstructive pulmonary disease? An exploratory study. Chron Respir Dis doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.